NCT04364048 2024-12-20
Durvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-small Cell Lung Cancer
Hoosier Cancer Research Network
Phase 2 Terminated
Hoosier Cancer Research Network
University of Wisconsin, Madison
H. Lee Moffitt Cancer Center and Research Institute
GBG Forschungs GmbH